1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Drug-Coated Balloons Market - Global Outlook and Forecast 2020-2025

Drug-Coated Balloons Market - Global Outlook and Forecast 2020-2025

  • November 2020
  • 263 pages
  • ID: 5724766
  • Format: PDF
  • Arizton

Summary

Table of Contents

Search Inside

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Drug-Coated Balloons Market Report

The drug-coated balloons market by revenue is expected to grow at a CAGR of 15% during the period 2019–2025.

The global drug-coated balloons market is one of the fastest-growing segments in the cardiovascular devices market. The market is growing significantly due to the surge in incidence/prevalence of cardiovascular diseases, especially peripheral artery and coronary artery diseases across the globe.

The COVID-19 pandemic is likely to profoundly affect the drug-coated balloons market in several countries across the globe. With the spread of the pandemic, several hospitals, CATH labs, and ASCs have experienced a rapid decline in the volume of elective cardiology procedures. Although COVID-19 is a global pandemic, some countries have experienced a higher incidence of the virus than others.

The following factors are likely to contribute to the growth of the the drug-coated balloons market during the forecast period:
• Expanding Indications of Drug-Coated Balloons
• Emergence of Latest Generation DCBs
• Growth in Target Patient Pool across the Globe

The study considers the present scenario of the drug-coated balloons devices market and its market dynamics for the period 2019?2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Global Drug-Coated Balloons Market Segmentation
The global drug-coated balloons market research report includes a detailed segmentation by indication, drug type, end-user, geography. The peripheral artery disease (PAD) segment accounted for a share of over 81% in 2019, and it is expected to retain its market dominance during the forecast period. The adoption of drug-coated balloons (DCB) for treating PAD is growing rapidly, primarily due to the availability of positive clinical data, supporting the safety and efficacy of DCB technology. The segment accounts for the largest share as the majority of DCB devices are commercially available for PAD indication. However, despite high potential growth opportunities for treating PAD, the recent COVID-19 pandemic has caused unprecedented challenges to perform PCI procedures. The spread of the virus has triggered disruption across the globe with lockdowns, travel bans, and ban on large gatherings such as major cardiac scientific society meetings being canceled, with substantial pressure on the health care services across the world.

The paclitaxel segment accounts for the maximum market share as these devices are safe and effective in treating CVDs, AV, and urological disorders. Paclitaxel-coated balloon (PCB) technology has emerged as a promising therapeutic alternative in the PCI procedure, especially for CVDs. The majority of commercially available DCBs are paclitaxel-coated. Paclitaxel-coated balloons are clinically proven, reducing the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. This is increasing their demand among healthcare professionals. In 2019, the sirolimus segment accounted for over 3% of the market. This segment is a new generation of DCBs, where balloons are coated with a medicine called sirolimus. There are a few commercially available sirolimus DCBs. Thus the contribution of the segment is low than paclitaxel-coated balloons.

The global drug-coated balloons market is segmented into hospitals, freestanding CATH labs, and ASCs. Healthcare professionals in hospitals use DCBs mainly for cardiovascular disorders, including AV interventions, urological, and neurovascular procedures. The segment is growing at a healthy rate due to the high adoption of the latest generation DCBs. A majority of patients with an increased risk of cardiovascular diseases prefer visiting hospitals for treatment due to advanced infrastructure facilities available in major private and public hospitals, the segment is expected to grow significantly.

By Indication
• PAD
• CAD
• Others
By Drug Type
• Paclitaxel
• Sirolimus
By End-user
• Hospitals
• Ambulatory Care Settings
• Freestanding Cath Labs

INSIGHTS BY GEOGRAPHY
North America occupies a dominant position in the global drug-coated balloons market. The presence of a large disease population, coupled with better access to treatment, is the primary factor for the high market share. The market in North America is expected to witness lucrative growth during the forecast period due to expanded indication approvals for commercialized DCBs, new product approvals, and the availability of abundant clinical evidence.

By Geography
• North America
o US
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
• APAC
o China
o Japan
o South Korea
o India
o Australia
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o Saudi Arabia
o Turkey
o South Africa
o Israel

INSIGHTS BY VENDORS
The global drug-coated balloons market is highly dynamic with the presence of global, regional, and local players offering a broad range of latest-generation DCBs for end-users. Medtronic, BD, Koninklijke Philips, Boston Scientific, and B. Braun Melsungen are the key vendors in the market in terms of technology, safety features, regulatory approvals, marketing strategies, and distribution channels.

Prominent Vendors
• Medtronic
• BD
• Koninklijke Philips
• Boston Scientific
• B. Braun Melsungen

Other Prominent Vendors
• Aachen Resonance
• Acotec Scientific
• AR Baltic Medical
• Biosensors International Group
• BIOTRONIK
• Cardionovum
• Concept Medical
• eucatech
• ENDOCOR
• HEXACATH
• iVascular
• M.A. Med Alliance
• Meril Life Sciences
• Nano Therapeutics
• QT Vascular
• RD Global-Invamed
• STENTYS
• Surmodics
• Terumo
• Urotronic
• Wellinq

KEY QUESTIONS ANSWERED
1. What is the drug-coated balloons market size and growth rate during the forecast period?
2. What are the factors impacting the growth of the drug-coated balloons market share?
3. What is the growth of North America drug-coated balloons market during the forecast period?
4. Who are the leading vendors in the drug-coated balloons market?
5. What is the impact of COVID-19 pandemic on the global market?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

North America Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Application ; End User and Country

  • $ 3000
  • November 2020
  • 109 pages

The North America neurovascular devices market is expected to reach US$ 1389.28 million by 2027 from US$ 1,004.75 million in 2019. The market is estimated to grow at a CAGR of 4.2% during the forecast ...

  • North America
  • Hospital
  • Neurological Disorder
  • Industry analysis
  • Hospital Revenue
  • Health Expenditure

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on